MAPCs

Athersys-Pfizer Investors: Anticipating A Phase III Trial For Inflammatory Bowel Disease
Seeking Alpha
Wed, 01/22/14 - 05:16 pm
Athersys
inflammatory bowel disease
MAPCs
Pfizer